Case Reports in Medicine

Case Reports in Medicine / 2011 / Article

Case Report | Open Access

Volume 2011 |Article ID 216404 | 2 pages | https://doi.org/10.1155/2011/216404

Rare Presentation of Rhino-Orbital-Cerebral Zygomycosis: Bilateral Facial Nerve Palsy

Academic Editor: Vincenzo Di Lazzaro
Received12 Oct 2010
Revised01 Jan 2011
Accepted18 Feb 2011
Published06 Apr 2011

Abstract

Rhino-orbital-cerebral zygomycosis afflicts primarily diabetics and immunocompromised individual, but can also occur in normal hosts rarely. We here presented an interesting case of facial nerve palsy and multiple cold abscesses of neck due to rhino-orbital-cerebral zygomycosis in an otherwise healthy man. Although some reports of facial nerve paralysis in conjunction with rhino-orbital-cerebral zygomycosis exist, no case of bilateral complete facial paralysis has been reported in the literature to date.

1. Introduction

The most common clinical presentation of zygomycosis is rhino-orbital-cerebral infection. The former, and more common, term “mucormycosis” is familiar to most clinicians. However, most mycologists prefer the term “zygomycosis” since other members of this class of fungi can also cause infection in the order Mucorales. Almost all patients with invasive zygomycosis have some underlying pathology that makes them susceptible to be infected. The most common underlying diseases are diabetes mellitus, metabolic acidosis, treatment with glucocorticoids or deferoxamine, hematologic malignancies, solid organ transplantation, iron overload, acquired immunodeficiency syndrome, injection drug use, trauma, burns, and malnutrition [1].

2. Case Report

In October 2008 a 43-year-old previously healthy man presented to our hospital with complain of headache, unilateral facial numbness in the distribution area of V1 and V2 branches of trigeminal nerve, facial nerve paralysis, proptosis, blindness due to optic nerve involvement, nasal obstruction, nasal discharge and aural fullness, and hearing impairment in the right side. All these symptoms were developed during a 15-day period. The patient did not have any positive history regarding chronic rhinosinusitis, recent dental problems, or local surgeries. About 48 hours after admission, he developed left-sided complete facial nerve paralysis in all branches (Figure 1).

Computed tomography scans of orbits, paranasal sinuses, temporal bone, and neck were performed. It demonstrated marked right proptosis, thickening of the extraocular muscles, opacification of right maxillary, ethmoid and sphenoid sinuses, bilateral opacification of mastoid air cells and middle ear spaces, as well as multiple cystic lesions in the neck (Figure 2). According to brain magnetic resonance imaging (MRI) brain stem and cavernous sinus remained intact. Consequently, extraocular muscles involvement was considered as cause of frozen eyes. Except V and VII other cranial nerves were normal. Biopsy of the involved tissues of his right nasal cavity and orbit confirmed zygomycosis. Consequently, patient underwent radical debridement of all involved sinuses, orbital exenteration, incision and drainage of parapharyngeal abscess, and myringotomy and aspiration of middle ear effusion. Histopathological evaluation showed coagulative necrosis, blood vessels thrombosis, and infiltration of broad, nonseptate hyphae with rightangle branching compatible with zygomycosis. Abscess fluid sample was containing fungal elements but middle ear fluid just showed inflammatory changes. Comprehensive immunologic evaluation including measurement of serum immunoglobulins, serum protein electrophoresis, human immunodeficiency virus (HIV) antibodies, antihuman T-lymphotropic virus type 1 and 2 antibodies, lymphocyte transformation time, bone marrow aspiration and trephine biopsy, and flow cytometry for determination of lymphocyte subpopulations was performed. There was a cell mediated immune deficiency with unknown cause including decreased natural killer cells, decreased T helper cells (CD4+) and increased T suppressor cells (CD8+). The patient received amphotericin B up to 3 grams. Results of repeated HIV test after 6 and 12 months were also negative. After one-year follow-up, he has been survived with no evidence of systemic or immunologic diseases or recurrence. Informed consent was obtained from the patient for printing his anonymous photos.

3. Discussion

Rhino-orbital-cerebral zygomycosis is most commonly caused by Rhizopus oryzae [1]. This infection afflicts primarily diabetics and other immunocompromised patients. In rare occasions it can infect normal hosts [2]. Our case had no obvious underlying disorder except a cell-mediated immune deficiency with unknown cause. There are few cases of zygomycosis in the literature secondary to various type of cell-mediated immunodeficiency [3]. Cyst formation in zygomycosis is very rare and has been reported as orbital or brain abscess in the literature [4]. The role of T cells in mediating protection against abscess formation by some bacterial species has been described [5]. However, the protective role of T cells in abscess formation by fungi in the cell-mediated immune deficiency is not clear now. Hearing impairment has been reported in 3.5% of cases in one study [2]. More reports cited facial nerve paralysis in conjunction with rhino-orbital-cerebral zygomycosis [6] with reported frequency of 11% [2]. According to our knowledge, there is no case of bilateral complete facial paralysis in the literature. No obvious pathophysiology for facial nerve paralysis has been proposed yet. Some researchers believe that infection can reach from the pterygopalatine fossa to inferior orbital fissure, orbital apex, and infratemporal fossa [6]. Whether or not the facial nerve is involved at stylomastoid foramen via mentioned pathway is not completely obvious. There is a need to conduct more studies regarding common spread pathways of rhino-orbital-cerebral zygomycosis with presumptive implication in more directed debridement procedures in early stages of the disease.

References

  1. G. M. Cox, “Zygomycosis (mucormycosis),” in UpToDate, D. S. Basow, Ed., UpToDate, Waltham, Mass, USA, 2009. View at: Google Scholar
  2. B. J. Ferguson, “Mucormycosis of the nose and paranasal sinuses,” Otolaryngologic Clinics of North America, vol. 33, no. 2, pp. 349–365, 2000. View at: Google Scholar
  3. M. Bongiovanni, R. Ranieri, D. Ferrari, C. Codecà, T. Tartaro, and L. Uziel, “Prolonged survival of an HIV-infected subject with severe lymphoproliferative disease and rhinocerebral mucormycosis [14],” Journal of Antimicrobial Chemotherapy, vol. 60, no. 1, pp. 192–193, 2007. View at: Publisher Site | Google Scholar
  4. N. Mnif, E. Hmaied, S. Oueslati et al., “Imaging of rhinocerebral mucormycosisL'imagerie dans la mucormycose rhinocérébrale,” Journal de Radiologie, vol. 86, no. 9, part 1, pp. 1017–1020, 2005. View at: Google Scholar
  5. A. O. Tzianabos and D. L. Kasper, “Role of T cells in abscess formation,” Current Opinion in Microbiology, vol. 5, no. 1, pp. 92–96, 2002. View at: Publisher Site | Google Scholar
  6. S. M. S. Hosseini and P. Borghei, “Rhinocerebral mucormycosis: pathways of spread,” European Archives of Oto-Rhino-Laryngology, vol. 262, no. 11, pp. 932–938, 2005. View at: Publisher Site | Google Scholar

Copyright © 2011 Alireza Mohebbi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1081 Views | 361 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.